Do Apixaban Plasma Levels Relate to Bleeding? The Clinical Outcomes and Predictive Factors for Bleeding in Patients with Non-Valvular Atrial Fibrillation

Apixaban can significantly prevent stroke events in patients with non-valvular atrial fibrillation (NVAF), as can be observed from the large, randomized, controlled trial conducted in the present study. However, the real-world evidence of bleeding events related to the apixaban plasma levels in Asia...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Sutee Limcharoen, Manat Pongchaidecha, Piyarat Pimsi, Sarawuth Limprasert, Juthathip Suphanklang, Weerayuth Saelim, Wichai Santimaleeworagun, Pornwalai Boonmuang
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2022-08-01
Serie:	Biomedicines
Soggetti:	non-valvular atrial fibrillation non-vitamin-K antagonist oral anticoagulants bleeding thromboembolic
Accesso online:	https://www.mdpi.com/2227-9059/10/8/2001
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!